Literature DB >> 25130222

End-of-life treatment preference among low-income older adults: a race/ethnicity comparison study.

Eunjeong Ko, Jaehoon Lee.   

Abstract

INTRODUCTION: Racial/ethnic minority older adults in low-income status might be at a greater risk than others of developing chronic illness. We sought to examine the effects of race/ethnicity on end-of-life (EOL) treatment preference among low-income older adults.
METHODS: A cross-sectional study surveyed 256 low-income older adults (90 Whites, 82 Hispanics, 84 Blacks) in a California city.
RESULTS: Hierarchical multiple regression results showed that participants with greater religiosity (p < .01) or more frequent doctors' visits (p < .05) had greater preference for life-sustaining treatments during the final phase of life. Conversely, those with greater comfort about death (p < .01) or a belief that life and death are predestined (p < .05) preferred life-sustaining treatments less often. Race/ethnicity had no significant relationship with EOL treatment preference after accounting for other factors.
CONCLUSION: Race/ethnicity encompasses multiple life contexts. Understanding the influences of both cultural beliefs and individual circumstances on EOL treatment preference is imperative.

Entities:  

Mesh:

Year:  2014        PMID: 25130222     DOI: 10.1353/hpu.2014.0129

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  2 in total

Review 1.  A Decade of Studying Drivers of Disparities in End-of-Life Care for Black Americans: Using the NIMHD Framework for Health Disparities Research to Map the Path Ahead.

Authors:  Elizabeth Chuang; Sandra Yu; Annette Georgia; Jessica Nymeyer; Jessica Williams
Journal:  J Pain Symptom Manage       Date:  2022-04-04       Impact factor: 5.576

2.  Exploring Advance Directive Perspectives and Associations with Preferences for End-of-Life Life-Sustaining Treatments among Patients with Implantable Cardioverter-Defibrillators.

Authors:  JinShil Kim; Hyung Wook Park; Minjeong An; Jae Lan Shim
Journal:  Int J Environ Res Public Health       Date:  2020-06-15       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.